A family’s concerns about their child’s growth led them to seek a diagnosis of Pediatric Growth Hormone Deficiency (PGHD). The child’s mother, Diane Benke, noticed that her son Alex was significantly shorter than his peers, despite being around the 50th percentile for weight. Benke’s instincts told her something was wrong, but their pediatrician reassured them that everything was fine.

Navigating the Diagnosis Process

Benke decided to seek an endocrinologist after a friend’s child was diagnosed with PGHD. The diagnosis process involved a series of evaluations, including bloodwork, a bone age X-ray, and a growth hormone stimulation test. The results confirmed the diagnosis of PGHD, a rare condition that affects an estimated 1 in 4,000-10,000 children.

Common signs of PGHD include a child being significantly shorter than their peers, slower growth rate, delayed puberty, reduced muscle strength, and slower bone development. Receiving the diagnosis was a relief for the family, as it provided clarity and a path forward.

Moving Forward with Treatment

Treatment for PGHD typically involves daily injections of a growth hormone. However, a long-acting growth hormone (LAGH) is now available, offering once-weekly dosing as an alternative to daily injections. The family had to navigate the insurance approval process, which required them to try a daily medication before approving a weekly option.

The weekly treatment option has made a positive impact on the family’s daily routine, with minimal disruptions and no missed doses. Benke advises other parents to trust their instincts and seek out a specialist if they have concerns about their child’s growth.

Original reporting: KTBS 3 (Shreveport) — read the source article.